Keystone Symposia

This meeting took place in 2020



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

MEETING CANCELLED: Transforming Vaccinology (L2)


Organizer(s) Rino Rappuoli, Lynda M. Stuart and Federica Sallusto
March 15—19, 2020
Firenze Fiera - Fortezza da Basso • Florence, Italy
Discounted Abstract Deadline: Nov 12, 2019
Abstract Deadline: Dec 10, 2019
Scholarship Deadline: Nov 12, 2019
Discounted Registration Deadline: Jan 14, 2020

Organized in collaboration with Menarini International Foundation

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation

Sponsored by GlaxoSmithKline Biologicals and Moderna

Summary of Meeting:
Along with clean water and antibiotics, vaccination has allowed mankind to conquer the infectious diseases that used to eradicate about 50% of children. Over the last century, vaccination has also extended life expectancy from under 50 to over 80 years of age. Now that the most important vaccines for infants and children are available, vaccination faces new challenges with the intent to bring the benefits of vaccines to other age groups, emerging infections, antimicrobial resistance, diseases that afflict low-income countries, and to improve therapies against chronic infectious diseases, cancer, autoimmune and neurodegenerative diseases. This new vaccine ambition is supported by the incredible advances in science and technology that make it technically possible to develop vaccines against many new targets and by innovative approaches to vaccine development for emerging infections and for diseases of low-income countries. The technologies that are transforming vaccinology are structure-based design, adjuvants, nucleic acid vaccines (especially RNA), viral vectors, systems biology, and controlled human infections. They are supported by scientific advances in human immunology, genomics, synthetic biology, molecular structure of antigens and antigen-antibody complexes, germinal centers, and microbiome. Conference participants will be exposed to the multidisciplinary technologies that are transforming vaccinology, including the efforts of CEPI, Bill and Melinda Gates Foundation and Wellcome Trust, to change the way vaccines are developed.

View Meeting Program

Scholarships/Awards


Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation


Oluwaseyi A. Ajagbe
University of Abuja, Nigeria

Jones Soladoye Akinbobola
University of Abuja, Nigeria

Olayinka Oluwafemi Asala
National Veterinary Research Institute, Nigeria

Paula Berguer
Leloir Institute, Argentina

Fabiana Bigi
Institute of Biotechnology, Argentina

Patchanee Chootong
Mahidol University, Thailand

Camila Coelho
NIAID, National Institutes of Health, USA

Andressa Fisch
University of Sao Paulo, Brazil

Denise Morais da Fonseca
Institute of Biomedical Sciences, Brazil

Katia Sanches Francoso
University of São Paulo, Brazil

Alba Marina Gimenez
Universidade de São Paulo, Brazil

Yanina Paola Hecker
National Scientific and Technical Research Council, Argentina

Rajesh Kumar
Translational Health Science and Technology Institute, India

Sanjeev Kumar
International Center for Genetic Engineering and Biotechnology, India

Chaniya Leepiyasakulchai
Mahidol University, Thailand

Jomkhwan Meerak
Chiangmai University, Thailand

Eliane Namie Miyaji
Instituto Butantan, Brazil

Vanessa S. Moraes
University of Georgia, USA

Rupal Ojha
Central University of Rajasthan, India

Ifeoma Agatha Onah
Dorben Polytechnic Abuja, Nigeria, Nigeria

Viswanathan Ramasamy
ICGEB, New Delhi, India

Andres Sanchez Alberti
Universidad de Buenos Aires - CONICET, Argentina

Hari Mohan Saxena
Guru Angad Dev Veterinary and Animal Sciences University, India

Ishaya S. Tekki
National Veterinary Research Institute, Nigeria

María Virginia Tribulatti
Instituto de Investigaciones Biotecnológicas, Argentina

The Moos-Miller Fund Recipients
Funded by The Moos-Miller Fund


Camila Raquel Rodrigues Barbosa
Institute René Rachou/ Oswaldo Cruz Foundation, Brazil